[EN] INDOLINE AND TETRAHYDROQUINOLINE SULFONYL INHIBITORS OF DIMETALLOENZYMES AND USE OF THE SAME<br/>[FR] INHIBITEURS DE TYPE INDOLINE ET TÉTRAHYDROQUINOLINE SULFONYLE DES DIMÉTALLO-ENZYMES ET LEUR UTILISATION
申请人:UNIV LOYOLA CHICAGO
公开号:WO2017011408A1
公开(公告)日:2017-01-19
Indoline and tetrahydroquinoline sulfonyl compounds that can inhibit DapE and/or bacterial metallo-β-lactamases ("MBLs"), such as NDM-1 are disclosed. Also disclosed are methods of treating an individual suffering from a bacterial infection using the compounds disclosed herein.
SUBSTITUTED DIAZEPINE SULFONAMIDES AS BOMBESIN RECEPTOR SUBTYPE-1 MODULATORS
申请人:Baker Robert K.
公开号:US20100317645A1
公开(公告)日:2010-12-16
Certain novel substituted diazepine sulfonamides are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same
申请人:LOYOLA UNIVERSITY OF CHICAGO
公开号:US10626087B2
公开(公告)日:2020-04-21
Indoline and tetrahydroquinoline sulfonyl compounds that can inhibit DapE and/or bacterial metallo-β-lactamases (“MBLs”), such as NDM-1 are disclosed. Also disclosed are methods of treating an individual suffering from a bacterial infection using the compounds disclosed herein.